Guardant Health Note11/1 (Principal)
|
5.9 |
$184M |
|
268M |
0.68 |
|
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
4.7 |
$146M |
+18%
|
136M |
1.08 |
|
Exact Sciences Corp Note 0.375% 3/0 (Principal)
|
4.3 |
$133M |
+9%
|
144M |
0.92 |
|
Novocure Note11/0 (Principal)
|
4.0 |
$125M |
|
136M |
0.92 |
|
Apogee Therapeutics
(APGE)
|
3.9 |
$122M |
+170%
|
1.8M |
66.45 |
|
Nuvasive Note 0.375% 3/1 (Principal)
|
3.5 |
$109M |
+41%
|
114M |
0.95 |
|
Neurocrine Biosciences
(NBIX)
|
3.2 |
$101M |
+2%
|
730k |
137.92 |
|
Argenx Se Sponsored Adr
(ARGX)
|
2.8 |
$87M |
+43%
|
220k |
393.72 |
|
Vaxcyte
(PCVX)
|
2.7 |
$83M |
-5%
|
1.2M |
68.31 |
|
Neogenomics Note 0.250% 1/1 (Principal)
|
2.7 |
$83M |
+57%
|
104M |
0.80 |
|
Dexcom Note 0.250%11/1 (Principal)
|
2.3 |
$72M |
+44%
|
65M |
1.10 |
|
Legend Biotech Corp Sponsored Ads
(LEGN)
|
2.2 |
$70M |
+121%
|
1.2M |
56.09 |
|
Insmed Note 1.750% 1/1 (Principal)
|
2.2 |
$69M |
+23%
|
65M |
1.07 |
|
Insulet Corp Note 0.375% 9/0 (Principal)
|
2.2 |
$69M |
+4%
|
66M |
1.04 |
|
Penumbra
(PEN)
|
2.1 |
$66M |
+32%
|
296k |
223.18 |
|
Maravai Lifesciences Hldgs I Com Cl A
(MRVI)
|
2.0 |
$63M |
+43%
|
7.2M |
8.67 |
|
Sarepta Therapeutics Note 1.250% 9/1 (Principal)
|
1.9 |
$59M |
|
51M |
1.17 |
|
Viking Therapeutics
(VKTX)
|
1.9 |
$59M |
NEW
|
713k |
82.00 |
|
Xenon Pharmaceuticals
(XENE)
|
1.8 |
$56M |
-20%
|
1.3M |
43.05 |
|
Irhythm Technologies
(IRTC)
|
1.8 |
$56M |
-14%
|
483k |
116.00 |
|
Align Technology
(ALGN)
|
1.8 |
$56M |
+15%
|
169k |
327.92 |
|
Bridgebio Pharma Note 2.250% 2/0 (Principal)
|
1.8 |
$55M |
|
67M |
0.82 |
|
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
|
1.7 |
$54M |
+240%
|
53M |
1.02 |
|
Guardant Health
(GH)
|
1.6 |
$51M |
+226%
|
2.5M |
20.63 |
|
Travere Therapeutics Note 2.500% 9/1 (Principal)
|
1.6 |
$50M |
|
56M |
0.89 |
|
Cg Oncology
|
1.6 |
$50M |
NEW
|
1.1M |
43.90 |
|
Keros Therapeutics
(KROS)
|
1.6 |
$49M |
-34%
|
737k |
66.20 |
|
Transmedics Group
(TMDX)
|
1.5 |
$45M |
+422%
|
615k |
73.94 |
|
Avadel Pharmaceuticals Sponsored Adr
(AVDL)
|
1.5 |
$45M |
NEW
|
2.7M |
16.89 |
|
Glaukos
(GKOS)
|
1.4 |
$43M |
+85%
|
451k |
94.29 |
|
Paragon 28
(FNA)
|
1.3 |
$42M |
|
3.4M |
12.35 |
|
Intuitive Surgical Com New
(ISRG)
|
1.3 |
$40M |
NEW
|
101k |
399.09 |
|
Day One Biopharmaceuticals I
(DAWN)
|
1.2 |
$36M |
-48%
|
2.2M |
16.52 |
|
Karyopharm Therapeutics Note 3.000%10/1 (Principal)
|
1.2 |
$36M |
|
66M |
0.54 |
|
Alphatec Hldgs Note 0.750% 8/0 (Principal)
|
1.1 |
$34M |
+21%
|
32M |
1.04 |
|
4d Molecular Therapeutics In
(FDMT)
|
1.1 |
$34M |
NEW
|
1.1M |
31.86 |
|
Orthopediatrics Corp.
(KIDS)
|
1.0 |
$32M |
|
1.1M |
29.16 |
|
Krystal Biotech
(KRYS)
|
1.0 |
$32M |
-9%
|
177k |
177.93 |
|
Relay Therapeutics
(RLAY)
|
1.0 |
$31M |
NEW
|
3.7M |
8.30 |
|
Ironwood Pharmaceuticals Com Cl A
(IRWD)
|
1.0 |
$30M |
NEW
|
3.5M |
8.71 |
|
Kiniksa Pharmaceuticals Com Cl A
(KNSA)
|
0.9 |
$28M |
NEW
|
1.4M |
19.73 |
|
Thermo Fisher Scientific
(TMO)
|
0.9 |
$27M |
-37%
|
47k |
581.21 |
|
Repligen Corporation
(RGEN)
|
0.8 |
$26M |
+39%
|
143k |
183.92 |
|
Nevro
(NVRO)
|
0.8 |
$26M |
|
1.8M |
14.44 |
|
Inspire Med Sys
(INSP)
|
0.7 |
$22M |
-45%
|
102k |
214.79 |
|
Cullinan Oncology
(CGEM)
|
0.7 |
$21M |
|
1.2M |
17.04 |
|
Tourmaline Bio
(TRML)
|
0.7 |
$21M |
|
907k |
22.90 |
|
Lexeo Therapeutics
(LXEO)
|
0.7 |
$21M |
NEW
|
1.3M |
15.68 |
|
Ironwood Pharmaceuticals Note 0.750% 6/1 (Principal)
|
0.6 |
$20M |
-46%
|
20M |
1.00 |
|
Haemonetics Corp Mass Note3/0 (Principal)
|
0.6 |
$20M |
NEW
|
22M |
0.92 |
|
Spyre Therapeutics Com New
(SYRE)
|
0.6 |
$20M |
|
515k |
37.93 |
|
BioMarin Pharmaceutical
(BMRN)
|
0.6 |
$19M |
NEW
|
219k |
87.34 |
|
Structure Therapeutics Sponsored Ads
(GPCR)
|
0.6 |
$19M |
+55%
|
436k |
42.86 |
|
BioCryst Pharmaceuticals
(BCRX)
|
0.6 |
$17M |
-40%
|
3.4M |
5.08 |
|
Iteos Therapeutics
(ITOS)
|
0.5 |
$16M |
NEW
|
1.2M |
13.64 |
|
Mineralys Therapeutics
(MLYS)
|
0.5 |
$15M |
-43%
|
1.1M |
12.91 |
|
Alector
(ALEC)
|
0.5 |
$14M |
-28%
|
2.4M |
6.02 |
|
Arcutis Biotherapeutics
(ARQT)
|
0.4 |
$13M |
NEW
|
1.3M |
9.91 |
|
Elevation Oncology
(ELEV)
|
0.4 |
$12M |
NEW
|
2.4M |
5.13 |
|
Bridgebio Pharma
(BBIO)
|
0.3 |
$11M |
NEW
|
345k |
30.92 |
|
Iovance Biotherapeutics
(IOVA)
|
0.3 |
$9.8M |
NEW
|
660k |
14.82 |
|
Deciphera Pharmaceuticals
(DCPH)
|
0.3 |
$9.6M |
-47%
|
610k |
15.73 |
|
Olema Pharmaceuticals
(OLMA)
|
0.3 |
$8.0M |
NEW
|
704k |
11.32 |
|
Pulmonx Corp
(LUNG)
|
0.2 |
$7.0M |
-4%
|
753k |
9.27 |
|
Cutera Note 4.000% 6/0 (Principal)
|
0.2 |
$6.4M |
|
29M |
0.22 |
|
Dbv Technologies S A Sponsored Adr
(DBVT)
|
0.2 |
$5.9M |
|
7.8M |
0.76 |
|
Cutera Note 2.250% 6/0 (Principal)
|
0.2 |
$5.7M |
-20%
|
25M |
0.23 |
|
Outset Med
(OM)
|
0.2 |
$5.3M |
|
2.4M |
2.22 |
|
Adaptive Biotechnologies Cor
(ADPT)
|
0.1 |
$4.4M |
|
1.4M |
3.21 |
|
Harrow Health
(HROW)
|
0.1 |
$1.7M |
-91%
|
126k |
13.23 |
|